how many people are on glp 1 drugs Just Americans taking GLP-1s now GLP-1 trends 2025: real-world data,

Gastrointestinal symptoms and occasional psychiatric concerns require monitoring

Prevalence of overweight, obesity, and extreme obesity among adults: united states, trends 19601962 through 20092010 (2019)

[DOI] [PubMed] [Google Scholar] 36

Shortages have led to repercussions from insurers and put people who need regular access to these medications at risk

In addition, GLP-1 can slow gastric emptying, reduce appetite in patients and thus reduce body mass, control blood pressure, regulate blood lipids and protect cardiovascular function, and has a low risk of hypoglycemia

144 GLP-1RAs and gastrointestinal cancers GLP-1 and its receptor agonists show some potential in the treatment of gastrointestinal cancers, although this remains an emerging area of research